47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,2 | 0,3 | 0,1 | -71,4 |
Gross profit (loss) | 0,5 | 1,8 | 4,6 | 160,1 |
EBITDA | 0,1 | 0,3 | -0 | -104,3 |
Short time liabilities | 5,1 | 3,8 | 2 | -46,5 |
Other operating costs | 0,2 | 0,1 | 0,1 | 5,8 |
Equity capital | 0,4 | 1,8 | 4,6 | 156,1 |
Operating profit (EBIT) | 0,1 | 0,3 | -0 | -111,4 |
Assets | 5,5 | 5,7 | 6,8 | 19,3 |
Net profit (loss) | 0,3 | 1,8 | 4,6 | 161,3 |
Cash | 0 | 0 | 0 | -40,9 |
Net income from sale | 9,1 | 10,3 | 11 | 5,9 |
Liabilities and provisions for liabilities | 5,2 | 3,9 | 2,2 | -44,6 |
Working assets | 1,6 | 1,7 | 2,8 | 59,1 |
Other income costs | 0 | 0,1 | 0 | -91 |
Depreciation | 0 | 0 | 0 | 13,2 |
% | % | % | p.p. | |
Profitability of capital | 84,7 | 96,8 | 98,7 | 1,9 |
Equity capital to total assets | 6,9 | 31,8 | 68,3 | 36,5 |
Gross profit margin | 5,5 | 17,1 | 42 | 24,9 |
EBITDA Margin | 1 | 2,8 | -0,1 | -2,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 202 | 133 | 67 | -66 |
Current financial liquidity indicator | 0.3131638467311859 | 0.4634271264076233 | 1.377685308456421 | 0,9 |
Net dept to EBITDA | -0.20198962092399597 | -0.10322993248701096 | 1.4282196760177612 | 1,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane